Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cinnie Yentia Soekojo, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Soekojo CY, Chng WJ. The evolution of immune dysfunction in multiple myeloma. Eur J Haematol. 2022 Nov; 109(5):415-424. PMID: 35880386.
    Citations:    Fields:    
  2. Soekojo CY, Chng WJ. Treatment horizon in multiple myeloma. Eur J Haematol. 2022 Nov; 109(5):425-440. PMID: 35880395.
    Citations:    Fields:    
  3. Girard LP, Soekojo CY, Ooi M, Chng WJ, de Mel S. Immunoglobulin M Monoclonal Gammopathies of Clinical Significance. Front Oncol. 2022; 12:905484. PMID: 35756635; PMCID: PMC9219578.
  4. Da Y, Goh GH, Lau T, Chng WJ, Soekojo CY. Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges. Front Oncol. 2022; 12:880923. PMID: 35692803; PMCID: PMC9174543.
  5. Soekojo CY, Chung TH, Furqan MS, Chng WJ. Genomic characterization of functional high-risk multiple myeloma patients. Blood Cancer J. 2022 01 31; 12(1):24. PMID: 35102139; PMCID: PMC8803925.
    Citations:    Fields:    Translation:Humans
  6. Jia Y, Zhou J, Tan TK, Chung TH, Wong RWJ, Chooi JY, Lim JSL, Sanda T, Ooi M, De Mel S, Soekojo C, Chen Y, Zhang E, Cai Z, Shen P, Ruan J, Chng WJ. Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma. Blood Cancer J. 2021 02 12; 11(2):32. PMID: 33579893.
    Citations: 3     Fields:    Translation:HumansCells
  7. Chong LL, Soon YY, Soekojo CY, Ooi M, Chng WJ, de Mel S. Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021 Mar; 159:103211. PMID: 33387628.
    Citations: 5     Fields:    Translation:Humans
  8. Wang C, Soekojo CY, Mel S, Ooi M, Chen Y, Goh AZK, Nagarajan C, Chng WJ. Natural History and Prognostic Factors at First Relapse in Multiple Myeloma. Cancers (Basel). 2020 Jul 02; 12(7). PMID: 32630644; PMCID: PMC7409309.
  9. Girard LP, Soekojo CY, Ooi M, Poon LM, Chng WJ, de Mel S. Immunoglobulin M Paraproteinaemias. Cancers (Basel). 2020 Jun 25; 12(6). PMID: 32630470; PMCID: PMC7352433.
    Citations: 4     
  10. Soekojo CY, Ooi M, de Mel S, Chng WJ. Immunotherapy in Multiple Myeloma. Cells. 2020 03 03; 9(3). PMID: 32138182.
    Citations: 13     Fields:    Translation:Humans
  11. Soekojo CY, Low JZ, Oh J, Ooi M, De Mel S, Chng WJ. Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center. Clin Lymphoma Myeloma Leuk. 2020 04; 20(4):e165-e170. PMID: 32019731.
    Citations: 1     Fields:    Translation:Humans
  12. Soekojo CY, Kumar SK. Stem-cell transplantation in multiple myeloma: how far have we come? Ther Adv Hematol. 2019; 10:2040620719888111. PMID: 31798820; PMCID: PMC6859676.
    Citations: 5     
  13. Soekojo CY, Kim K, Huang SY, Chim CS, Takezako N, Asaoku H, Kimura H, Kosugi H, Sakamoto J, Gopalakrishnan SK, Nagarajan C, Wei Y, Moorakonda R, Lee SL, Lee JJ, Yoon SS, Kim JS, Min CK, Lee JH, Durie B, Chng WJ. Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network. Blood Cancer J. 2019 10 08; 9(10):83. PMID: 31594919; PMCID: PMC6783445.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  14. Soekojo CY, Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, Poon LM, de Mel S, Koh LP, Tan LK, Ooi MG, Nagarajan C, Liu Y, Lai YY, Huang XJ, Spencer A, Gopalakrishnan SK, Lu J, Chng WJ. Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis. Clin Lymphoma Myeloma Leuk. 2019 08; 19(8):e470-e477. PMID: 31171473.
    Citations: 2     Fields:    Translation:Humans
  15. Teoh PJ, An O, Chung TH, Chooi JY, Toh SHM, Fan S, Wang W, Koh BTH, Fullwood MJ, Ooi MG, de Mel S, Soekojo CY, Chen L, Ng SB, Yang H, Chng WJ. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood. 2018 09 20; 132(12):1304-1317. PMID: 30061158.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  16. Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Potential Clinical Application of Genomics in Multiple Myeloma. Int J Mol Sci. 2018 Jun 10; 19(6). PMID: 29890777.
    Citations: 3     Fields:    Translation:Humans
  17. Ei Ei Khaing N, Shyong TE, Lee J, Soekojo CY, Ng A, Van Dam RM. Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population. PLoS One. 2018; 13(4):e0196328. PMID: 29694442; PMCID: PMC5919010.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Soekojo's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (65)
Co-Authors (1)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.